EU Authority Mulls Paying For Late-Stage Research As A Pull Incentive For Neglected Disease Drugs

 
• By Francesca Bruce

It is time for a much greater focus on pull incentives to ensure viable market conditions for medicines for neglected diseases that are traditionally regarded as unprofitable.

Push Pull
More Pull Incentives For Neglected Disease Treatments Are Required • Source: Shutterstock

More from Europe

More from Geography